Hedge funds help biotech pioneer Palleon raise $100m

Sergio BarretoSeptember 17, 2020

1 minute read

Hedge funds help glycobiology pioneer Palleon raise $100 million — Palleon Pharmaceuticals via Twitter

Hedge fund Matrix Capital Management led a $100 million Series B round for Palleon Pharmaceuticals, a leader in the emerging field of glycobiology.

The funding will help . . .

Continue Reading With a Free Trial

Unlock this article instantly, along with the rest of our premium content, newsletters and mandate charts.

Already a subscriber? Log in.

Sergio Barreto

Sergio Barreto is about 70% journalist, 30% tech geek. As an editor for The ABIS Group, he produces daily newsletters for leading healthcare and technology companies. With BMV Digital, he provides WordPress-based web developments services. Here at Alternatives Watch, he wears both hats - handling IT and occasionally writing about the intersection of alts, healthcare and tech.